TAOP - DD CNCE among premarket losers

Concert Pharmaceuticals (CNCE) -47% after CTP-692 study in schizophrenia fails to meet primary or secondary endpoint.Universal Security Instruments (UUU) -18%.Quotient (QTNT) -15% despite FQ3 beat.Yield10 Bioscience (YTEN) -14% after pricing share offering.17 Education & Technology Group (YQ) -14%.Iconix Brand Group (ICON) -13%.DuPont de Nemours (DD) -11% on sale of its Clean Technologies unit.PEDEVCO (PED) -11%.Nano-X Imaging (NNOX) -11% after receiving additional information request from FDA in connection with its review of Nanox.ARC.Star Bulk Carriers (SBLK) -10%.New Concept Energy (GBR) -10%.Catabasis Pharmaceuticals (CATB) -11%.Siebert Financial (SIEB) -10%.Taoping (TAOP) -7%.Xcel Brands (XELB) -6%.CorEnergy Infrastructure Trust (CORR) -5%.Express (EXPR) -5%.

For further details see:

DD, CNCE among premarket losers